NCCN Awards Research Grants to Five Investigators to Study Effectiveness of Enzalutamide in Various Cancers

The NCCN Oncology Research Program has awarded five research grants to investigate the effectiveness of enzalutamide in mantle cell lymphoma and endometrial, hepatocellular, and prostate cancers. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has awarded five grants to investigators to evaluate and define the pre-clinical and clinical effectiveness of enzalutamide in mantle cell lymphoma and endometrial, hepatocellular, and prostate ca...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news